2021
Socioeconomic Determinants of the Use of Molecular Testing in Stage IV Colorectal Cancer
Punekar S, Griffin M, Masri L, Roman S, Makarov D, Sherman S, Becker D. Socioeconomic Determinants of the Use of Molecular Testing in Stage IV Colorectal Cancer. American Journal Of Clinical Oncology 2021, 44: 597-602. PMID: 34753883, DOI: 10.1097/coc.0000000000000875.Peer-Reviewed Original ResearchConceptsStage IV colorectal cancerKRAS testingColorectal cancerMedicaid insuranceMultivariable-adjusted Cox proportional hazards modelsStage IV colorectal adenocarcinomaEpidermal growth factor receptor monoclonal antibodiesCox proportional hazards modelMultivariable logistic regression modelAdvanced colorectal cancerEnd Results (SEER) databaseRisk of deathReceptor monoclonal antibodyProportional hazards modelWild-type KRASSocioeconomic disparities persistLogistic regression modelsCRC patientsResults databaseColorectal adenocarcinomaKRAS mutationsHigher median household incomeHazards modelPatientsMolecular testing
2020
Association of socioeconomic status and molecular testing in stage IV colorectal cancer.
Punekar S, Griffin M, Masri L, Makarov D, Sherman S, Becker D. Association of socioeconomic status and molecular testing in stage IV colorectal cancer. Journal Of Clinical Oncology 2020, 38: e19023-e19023. DOI: 10.1200/jco.2020.38.15_suppl.e19023.Peer-Reviewed Original ResearchStage IV colorectal cancerKRAS testingColorectal cancerMedian household incomeMedicaid insuranceMolecular testingStage IV colorectal adenocarcinomaCox proportional hazards modelMultivariable logistic regression modelImpact of KRASAdvanced colorectal cancerEnd Results (SEER) databaseMajority of patientsRisk of deathEGFR monoclonal antibodyWild-type KRASProportional hazards modelLogistic regression modelsMedian survivalCRC patientsRectal cancerSurveillance EpidemiologyContemporary cohortDiagnosis yearResults database